Programme and Speakers
Translation 2024 has a busy programme of speakers from industry and academia. We will be announcing the full programme of speakers shortly.
Day 1: Thursday 18th April
PRE-CONFERENCE ECR WORKSHOP - 10.00 |
|
MAIN CONFERENCE OPENS AT 12.00 for posters and lunch |
|
 |
|
Biomarkers
Session Chair: Professor James Rowe, University of Cambridge
 |
Keynote speaker: Professor Charlotte Teunissen Amsterdam UMC, Leading researcher into blood biomarkers for dementia. The biomarker revolution |
Session speakers:
 |
Dr. Do Geun Kim, Korea Brain Research Institute
Identification of inflammatory biomarkers of neurodegenerative diseases from KNU-KBRI collaborative project of S. Korea |
 |
Dr. Nick Ashton, University of Gothenburg The meaning of increased phosphorylated tau in blood: amyloid pathology, tau pathology or something else? |
 |
Professor Cornelia van Duijn, University of Oxford Disentangling the interplay between age, ageing and AD using blood-based biomarkers |
Flash Talks by
Dr Andrea Du Preez (King’s College, London)
Dr Elijah Mak (Cambridge University)
General Discussion
Close 5.00 pm followed by a drinks reception (until 6.00 pm)
DAY 2: FRIDAY 19TH APRIL -
BIG DATA - 09.00
Session Chair: Professor Simon Thompson, Swansea University
 |
Keynote speaker: Professor David Bennett Neurologist, Professor David Bennett, is director of the Alzheimer’s Disease Center at Rush University, Chicago, Illinois, USA. |
 |
Professor Ira Haraldsen, Oslo University Hospital AI-Mind - Applying machine learning to neurodegeneration |
 |
Dr. Robin Wolz, IXICO Using AI and contextualised data to develop disease-specific neuroimaging biomarkers for clinical trials |
 |
Professor David Llewellyn, University of Exeter Machines and minds: AI is a double-edged sword in the fight against dementia |
Flash Talks by
General Discussion
Ben Draper, University of Sheffield
Dr Danielle Newby, Oxford University
|
LUNCH Served in the Congress Suite 12.40 pm |
This is an opportunity to look at the poster presentations and visit the exhibition stands |
TRIALS DELIVERY
Session Chair: Dr Vanessa Raymont, Oxford University
 |
Keynote speaker: Hilary Evans Chief Executive, Alzheimer's Research UK & Co-Chair of the Dame Barbara Windsor Dementia Mission. The UK goes large |
 |
Dr Lynne Hughes, GAP Leveraging biomarker trials to phenotype participants for interventional trials: BioHermes & Apheleia |
 |
Victoria Breeden, Lilly An industry perspective on the UK clinical trials environment. |
 |
Professor Robert Perneczky, LMU Hospital, Munich The International Registry for Alzheimer’s Disease and Other Dementias (InRAD): A new platform for real-world data collaborations |
Flash Talks by
Dr Ta Wei Guu, King’s College London
Nishat Tahira and Dishaa Sinha, Oxford University
General Discussion
|
Professor John Gallacher, Oxford University Closing Address: The future landscape |
The conference ends at 5.20 pm
Conference sponsors:
